BT1769
BT1769 is a MT1-MMP-targeted (KD = 3.35 nM) Bicycle toxin conjugate. BT1769 can be used in the study for osteosarcoma. BT1769 consists of a novel bicyclic targeting peptide that selectively binds MT1-MMP; a cytotoxin MMAE; and an enzymatically cleavable dipeptide linker.
Nur für Forschungszwecke. Wir verkaufen nicht an Patienten.
- Formel: C186H269N43O50S
- Molecular Weight:3939.45
-
Speicherung:
Please store the product under the recommended conditions in the Certificate of Analysis.
Biologische Aktivität
Chemical Information
-
Molecular Weight 3939.45
-
Formel C186H269N43O50S
-
Sequence
4-Pentynoic acid-βAla-Sar-Sar-Sar-Sar-Sar-Sar-Sar-Sar-Sar-Sar-Ala-Dap(Me)-Ala-Asn-Glu-1Nal-Ala-Cys-Glu-Asp-Phe-Tyr-Asp-Tle-Dap(Me)-NH2(Dap(Me)&Cys bridged with TBMB)(Click with Azidoacetic acid-Val-Cit-PAB-MMAE)
-
Versand
Room temperature in continental US; may vary elsewhere.
-
Speicherung
Please store the product under the recommended conditions in the Certificate of Analysis.
Reinheit & Dokumentation
Verweise
Calculators
Konzentration (Stammlösung) × Volumen (Stammlösung) = Konzentration (Ziellösung) × Volumen (Ziellösung)